Trials / Completed
CompletedNCT07225647
A Study to Assess the Effect of Food on the Drug Levels of Admilparant
An Open-Label, Randomized, Two-part Study in Healthy Participants to Assess the Food Effect on the Pharmacokinetics of Admilparant To-Be-Marketed Tablet Formulations
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 56 (actual)
- Sponsor
- Bristol-Myers Squibb · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to assess the effect of food on the drug levels of Admilparant
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Admilparant | Specified dose on specified days |
Timeline
- Start date
- 2025-11-07
- Primary completion
- 2026-01-05
- Completion
- 2026-01-05
- First posted
- 2025-11-10
- Last updated
- 2026-01-14
Locations
2 sites across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT07225647. Inclusion in this directory is not an endorsement.